Jai Corp DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.76×0.88×0.80×0.71×−1.02×
2.11×4.52×2.01×1.98×0.34×
10.7%8.3%8.0%8.0%6.6%
0.34×0.34×0.34×0.30×0.39×
1.03×1.03×1.03×1.03×1.03×
6.0%11.5%4.5%3.5%−0.9%
11.7%11.7%4.6%3.6%−0.9%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

JAICORPLTD₹88.92

Jai Corp Limited

· Capital Goods & Defence
₹ CrorePeersJISLJALEQSAPOLLOPIPEPREMIERPOLPRINCEPIPEKRITIKINGFATAINWALCHMMcap ₹1,561 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×-1.020.710.800.880.76
Interest Burden (Pretax/EBIT) ×0.341.982.014.522.11
EBIT Margin %6.598.027.998.3110.71
Asset Turnover ×0.390.300.340.340.34
Financial Leverage (Assets/Equity) ×1.031.031.031.031.03
ROE (5-step product, year-end total equity) %-0.923.504.5011.556.05
ROE (owners' profit / average owners' equity) %-0.943.604.6011.6911.69
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.